Japer Share Price

Japer Share Price

NASDAQ: JSPRW | Healthcare
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Japer Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Japer Share Price Chart

$0.00$0.00
L
Show Current Price
H

Japer Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$0.00
Return On Equity (TTM)
-2248.48%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
85.27%

Japer Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$18.74-$9.10-$1.17-$2.76
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A51.44%87.14%-135.90%

Japer Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$37.69-$64.47-$71.27-$75.80
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-71.05%-10.55%-6.36%

Japer Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets1.134.095.956.63
Current Assets34.6575.8188.9441.73
Total Assets35.7879.994.8948.36
Non Current Liabilities18.432.994.085.16
Current Liabilities13.215.2412.377.07
Total Liabilities31.6318.2316.4512.22
Shareholders' Equity4.1561.6778.4436.14

Japer Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-77.16-62.6-52.07-45.86
Investing0.01-0.53-0.27-0.58
Financing34.2147.88100.970.06

About Japer

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Japer Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %

Japer Share Price FAQs